Vevye eye drops for blocked oil glands in the eyelids
Treatments studied
Part of Eyes & vision clinical trials.
This study tests if Vevye eye drops can improve symptoms of meibomian gland dysfunction, a condition where the tiny oil glands in your eyelids get blocked. It may help reduce dryness and discomfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You should have moderate to severe eye dryness
- You need to have signs of inflamed eyelids and damaged eye surface
- You must have blocked oil glands in your eyelids
- You should produce enough tears (wetness) on your eye
- You must not be using certain other eye drops or treatments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment called TearCare for young adults with a common type of dry eye caused by blocked oil glands in the eyelids. TearCare uses gentle heat to help unblock those glands and improve eye comfort.
This study tests a combination of two eye drop medications (Vevye and Flarex) to see if they work better together for treating moderate to severe dry eye. If you have persistent dry eye that hasn't improved with other treatments, this trial might help you and advance treatment options.
This study tracks whether VEVYE®, a prescription eye drop, reduces dry eye symptoms and signs in people who have both a neuro-ophthalmic condition (a nerve or brain issue affecting the eyes) and dry eye disease. You'll visit the clinic for 6 months and answer questions about your eye comfort.
This study tests whether a nasal spray can improve dry eye symptoms and tear production in people with mild to moderate meibomian gland dysfunction (a common cause of dry eye). You'll use the spray daily while the research team monitors your eye health and comfort over several weeks.
This study compares two different cyclosporine eye drops to see which one better improves the health of the surface of your eye. One is a newer version (Vevye) and the other is a generic version of Restasis, over 8 weeks of treatment.
This trial tests a special eyelid massage device to see if it helps people with dry eye caused by blocked oil glands in the eyelids. It may improve symptoms and eye comfort.
Hear when a new Meibomian Gland Dysfunction (MGD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.